Emerging treatments in CLL: Expert Discussion

Thrombosis in adult patients with chronic ITP

Hot topic: B-cell depletion in adult chronic ITP

Treatment options in adult chronic idiopathic thrombocytopenic purpura: Introduction

How do TPO-R agonists impact the daily lives of chronic ITP patients? Lessons from long-term studies

Prolonged response to TPO-R agonists

Effects of one TPO-R agonist after discontinuing another?

Global prostate cancer disparities and the parts both genetic and behavioural factors play

New players and targets in tumour vasculature

ecancermedicalscience editor's choice for July and August 2014

Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion

Biochips separate cancer cells from blood cells